Exjade and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Exjade (deferasirox), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Pegasys, and have Haemochromatosis.

The phase IV clinical study analyzes which people have Uveitis when taking Exjade. It is created by eHealthMe based on reports of 29,418 people who have side effects when taking Exjade from the FDA, and is updated regularly.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,533 conditions by eHealthMe. Check the latest studies of Uveitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

29,418 people reported to have side effects when taking Exjade.
Among them, 11 people (0.04%) have Uveitis.

Among these 11 people:

How long have people been on Exjade when they have Uveitis? *

What is the gender of people who have Uveitis when taking Exjade? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Uveitis when taking Exjade? *

What are other drugs people take besides Exjade? *

Ribavirin: 4 people, 36.36%
Pegasys: 4 people, 36.36%
Zantac: 1 person, 9.09%
Azithromycin: 1 person, 9.09%

What are other side effects people have besides Uveitis? *

Weakness: 6 people, 54.55%
Vitreous Floaters (spots before the eyes): 6 people, 54.55%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 6 people, 54.55%
Eye Inflammation: 6 people, 54.55%
Chest Pain: 6 people, 54.55%
Blindness Unilateral: 6 people, 54.55%
Blood Iron Abnormal: 5 people, 45.45%
Haemoglobin Decreased: 4 people, 36.36%
Urinary Tract Infection: 3 people, 27.27%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 9.09%

What are the existing conditions these people have? *

Haemochromatosis (body to absorb more iron than usual from food): 6 people, 54.55%
Liver Disorder (liver diseases): 4 people, 36.36%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 27.27%
Cardiac Disorder: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Exjade and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exjade:

Exjade (29,456 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,533 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.